Less than 1% of myeloblasts from healthy donors stained positive for phosphorylated ATM, whereas a substantial fraction of myeloblasts from either high-risk MDS or AML patients exhibited positive pATM staining. This evidence concerns the gene ATM and myelodysplastic syndrome.